Use of granulocyte colony‐stimulating factor (G‐CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration
- 1 January 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 86 (1), 180-182
- https://doi.org/10.1111/j.1365-2141.1994.tb03271.x
Abstract
Peripheral blood stem cells have been used for autologous reconstitution of haemopoiesis after high dose cytotoxic therapy and produce similar disease response rates as autologous bone marrow transplants. Peripheral blood stem cell transplants are an especially attractive option for patients in whom marrow harvest is not feasible due to bone marrow damage or infiltration. Recombinant growth factors mobilize adequate numbers of stem cells from the marrow but their effect on tumour cell circulation kinetics is not known. We report a patient with multiple myeloma and bone marrow infiltration in whom the use of G-CSF for stem cell mobilization led to release of plasma cells into the peripheral circulation and contamination of the stem cell harvest.Keywords
This publication has 4 references indexed in Scilit:
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Comparison of haematological recovery, toxicity and supportive care of autologous PBSC, autologous BM and allogeneic BM transplantsThe International Journal of Cell Cloning, 1992
- Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesionBritish Journal of Haematology, 1991
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989